---
pmid: '31864703'
title: Structural basis for the recognition of RFX7 by ANKRA2 and RFXANK.
authors:
- Gao J
- Xu C
journal: Biochem Biophys Res Commun
year: '2020'
full_text_available: false
doi: 10.1016/j.bbrc.2019.12.059
---

# Structural basis for the recognition of RFX7 by ANKRA2 and RFXANK.
**Authors:** Gao J, Xu C
**Journal:** Biochem Biophys Res Commun (2020)
**DOI:** [10.1016/j.bbrc.2019.12.059](https://doi.org/10.1016/j.bbrc.2019.12.059)

## Abstract

1. Biochem Biophys Res Commun. 2020 Feb 26;523(1):263-266. doi: 
10.1016/j.bbrc.2019.12.059. Epub 2019 Dec 19.

Structural basis for the recognition of RFX7 by ANKRA2 and RFXANK.

Gao J(1), Xu C(2).

Author information:
(1)Hefei National Laboratory for Physical Sciences at Microscale and School of 
Life Sciences, University of Science and Technology of China, Hefei, Anhui, 
230027, People's Republic of China.
(2)Hefei National Laboratory for Physical Sciences at Microscale and School of 
Life Sciences, University of Science and Technology of China, Hefei, Anhui, 
230027, People's Republic of China. Electronic address: xuchaor@ustc.edu.cn.

RFX7 is an important member in the RFX family of DNA binding proteins and plays 
critical roles in natural killer cell-mediated immunity and neuron development. 
Our previous work identified ANKRA2 and RFXANK as the potential binding partners 
of RFX7. Here we present two structures of a RFX7 fragment, with one bound with 
the ANKRA2 ankyrin domain and the other bound to the RFXANK ankyrin domain. Our 
structural analysis reveals that both ANKRA2 and RFXANK recognize the PXLPXL 
motif of RFX7 and its flanking sequences via extensive hydrophobic interactions. 
Detailed structural comparison also provides an explanation for the different 
RFX7 binding affinities of ANKRA2 and RFXANK. Thus our work would provide clue 
to the understanding the roles of ANKRA2 and RFXANK in the RFX7-associated 
signaling pathway.

Copyright Â© 2019 Elsevier Inc. All rights reserved.

DOI: 10.1016/j.bbrc.2019.12.059
PMID: 31864703 [Indexed for MEDLINE]

Conflict of interest statement: Declaration of competing interest The authors 
declare no conflict of interests.
